Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

601
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
601
Next-generation Sequencing03:00

Next-generation Sequencing

97.9K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
97.9K
Genomics02:02

Genomics

39.7K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.7K
DNA Microarrays02:34

DNA Microarrays

20.7K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
20.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Adulthood Outcomes Among Individuals With Neurologic Impairment and Technology Assistance.

Pediatrics·2026
Same author

Previable Preterm Premature Rupture of the Membranes Reaching Viability: Canadian Outcomes.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2026
Same author

Development and content validation of the Clinician-reported Genetic testing Utility InDEx for genomic newborn screening (C-GUIDE NBS).

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

An Empirical Comparison of Statistical Methods for Estimating Treatment Effects on EQ-5D in Randomized Clinical Trials.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Understanding the decision of parents to opt-out of medically actionable secondary findings offered through genome sequencing.

Journal of genetic counseling·2026
Same author

Correction: The development and usability of 'The Genetics Navigator': a digital solution for adult and paediatric clinical genetics services.

European journal of human genetics : EJHG·2026

Related Experiment Video

Updated: Jan 19, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.2K

Genome Diagnostics: Novel Strategies for Measuring Value.

Robin Z Hayeems1, Stephanie Luca2, Eleanor Pullenayegum1

  • 1The Hospital for Sick Children Research Institute and The University of Toronto, Toronto, Ontario, Canada.

Journal of Managed Care & Specialty Pharmacy
|September 27, 2019
PubMed
Summary

This study introduces a new methodology for evaluating the value of genetic testing in personalized medicine. It develops clinician- and patient-reported measures to assess the informational value of genome diagnostic tests.

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

9.0K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.4K

Related Experiment Videos

Last Updated: Jan 19, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.2K
A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

9.0K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.4K

Area of Science:

  • Genomics and Personalized Medicine
  • Health Services Research
  • Measurement Science

Background:

  • Genetic testing is advancing rapidly, driven by personalized medicine.
  • Current evaluation methods for genetic tests often rely on laboratory performance, which can be costly and complex.
  • A comprehensive assessment of value is needed to guide the adoption and use of these tests.

Purpose of the Study:

  • To develop novel clinician- and patient-reported measures of clinical and personal utility for genome diagnostic tests.
  • To capture the informational value of genetic tests beyond traditional laboratory performance metrics.
  • To inform the adoption and appropriate use of genetic testing in personalized medicine.

Main Methods:

  • A 4-step methodology adhering to measurement science principles.
  • Tool development via scoping reviews, stakeholder interviews, and surveys.
  • Tool validation through prospective cohort studies and comparative effectiveness assessment.
  • Dissemination leveraging international partnerships for further research and policy development.

Main Results:

  • A preliminary 25-item index was informed by a literature review.
  • Qualitative interviews and surveys with clinicians refined the utility construct and item content.
  • An 18-item "Clinician-reported Genetic testing Utility InDEx" (C-GUIDE) is undergoing validation.
  • A patient-reported measure is also under development.

Conclusions:

  • This innovative methodology provides stakeholder-informed, clinimetrically sound measures of value for personalized medicine tests.
  • The developed tools will aid global technology users and decision-makers in evaluating genetic tests.
  • This approach supports evidence-informed policy and the appropriate use of genetic diagnostics.